Lecture 9+10 Flashcards

1
Q

ARB examples

A

Losartan / Valsartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ARB drug MOA

A

first-line agents
alternative for those that cant have ACEI’s

Block angiotensin-2 type 1 receptors:

decrease BP by causing arteriolar & venous dilation

Block aldosterone secretion → decrease Na+ & H20
retention

decrease diabetic nephropathy

DOES NOT increase bradykinin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

AE’a of the ARB’s

A

Similar to those of ACE inhibitors

Dry cough does not occur

Angioedema risk is significantly lower than with
ACEI’s

Losartan reduces plasma uric acid levels by inhibiting
URAT1 transporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ARB contraindication

A

Pregnancy

Patients with bilateral renal artery stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

renin inhibitor example

A

Aliskiren

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of renin inhibtors

A

Inhibits enzyme activity of renin and prevents conversion of angiotensinogen into angiotensin I

Inhibits production of both angiotensin II and
aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

AE of renin inhibitors

A

• Similar to those of ACE inhibitors
• Dry cough does not occur (due to no effect on
bradykinin levels)
• Angioedema risk is significantly lower than with
ACEI’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

examples of Ca channel blockers

A

first line for black/elderly patients

non-dihydropyridines:
Verapamil / Diltiazem

Dihydropyridines:
Nifedipine / Amlodipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

verapamil

A

non-dihydropyridine

Significant effects in cardiac & vascular smooth muscle

Used to treat angina, supraventricular tachyarrhythmias, hypertension, migraine & cerebral vasospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diltiazem

A

non-dihydropyridine

Effects in both cardiac & vascular smooth muscle

Used to treat angina, hypertension, supraventricular
tachyarrhythmias & cerebral vasospasm

good side-effect profile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Amlodipine and nifedipine

A

dihydropyridines

Greater affinity for vascular Ca2+-channels than for cardiac Ca2+-channels

Reduce Ca2+ entry into smooth muscles to cause
coronary & peripheral vasodilatation & lower BP

Primarily used in treating hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA of Ca blockers

A

If you block the Ca channel… there is less movement of Ca, and thus decreased force of muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

clinical apps. of Ca blockers

A

• Hypertension (1st line, particularly for black and/or
elderly patients)
• Have intrinsic natriuretic effect (no need for diuretic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

risk of taking Ca channel blockers

A

increased risk of MI ((excessive vasodilation & reflex cardiac stimulation)

High-doses of short-acting dihydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AE of verapamil

A

Constipation (~7%), negative inotropic effects, gingival

hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AE of Diltiazem

A

Negative inotropic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

AE of the dihydropyridine’s

A

Hypotension, peripheral edema (esp. feet & ankles),
dizziness, headache, fatigue, gingival hyperplasia,
flushing, reflex tachycardia can occur (especially in
short-acting preparations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

contraindications of the dihydropyridine’s

A

in patients taking b-blockers, or who have 2nd or 3rd degree AV block, or severe left ventricular systolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

use thiazides 1st line for?

A

first line treatment for most, especially AA and elderly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

when to use loop diuretics

A

Used primarily in patients who do not respond to

thiazide therapy adequately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

beta blockers

A

Propranolol / Metoprolol / Atenolol / Pindolol

Used only as add-on therapy to first line agents in
primary prevention patients

First-line therapy only for patients with coronary
artery disease, heart failure or post-MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MOA of the Beta blockers

A

Reduce BP by cardiac output, contractility & heart rate

Inhibit both release of norepinephrine and renin (b1 R) (→ decrease in angiotensin II & aldosterone secretion)

takes weeks to develop full effects

23
Q

AE of beta blockers

A
hypoglycemia 
bradycardia 
hypotension 
decreased libido 
disrupted lipid metabolism 

no one can take if they have pulmonary issue

24
Q

alpha blocker examples

A

Prazosin / Doxazosin

25
MOA of alpha blockers
Competitively block a1 -adrenoceptors decreased peripheral vascular resistance & arterial BP by relaxing both arterial & venous smooth muscle no long term tachy can have H20 and Na retention can lower BP.. but have more AE
26
clinical app of alpha blockers
hypertension benign prostatic hyperplasia Have been used in heart failure
27
AE of alpha blockers
orthostatic hypotension Dizziness, drowsiness, headache, lack of energy, nausea, and palpitations, Doxazosin shown to increase rate of congestive HF
28
mixed alpha and beta blocker | used? adverse?
labetalol Used in hypertension management (safe in pregnancy) IV labetalol = rapid reduction in BP no reflex increase in HR or cardiac output AE: orthostatic hypotension
29
central alpha2 agonist
clonidine reduces sympathetic outflow decrease in PVR and CO = lower BP does not decrease renal blood flow used in HTN management or crisis
30
clonidine AE
Drowsiness, dry mouth, dizziness, headache & sexual dysfunction occur commonly Rebound hypertension may occur following abrupt withdrawal
31
methyldopa
central alpha2 agonist decrease peripheral resistance and BP does not decrease renal blood flow or CO used for pregnancy induced HTN or HTN management
32
AE of methyldopa
Sedation, drowsiness, dizziness, nausea, headache, weakness, fatigue, sexual dysfunction, hypoprolactinemia Nightmares, mental depression, vertigo (infrequent) can develop of + coomb's test (long term)
33
direct vasodilators
Hydralazine / Minoxidil not first line for HTN direct acting on SM Produce reflex tachycardia, increase plasma renin → Na+ & H20 retention Major side effects can be blocked if combined with diuretic & b-blocker
34
hydralazine
direct vasodilator acts mainly on the arterioles Used to treat pregnancy induced hypertension / preeclampsia Used in management of hypertension as last-line therapy
35
AE of hydralazine
Fluid retention & reflex tachycardia are common Reversible lupus-like syndrome Headache, nausea, sweating, flushing Usually administered with b-blocker & thiazide
36
minoxidil
direct acting vasodilator Causes direct peripheral vasodilatation of arterioles Oral treatment for severe-malignant hypertension (refractory to other treatments)
37
AE of minoxidil
Reflex tachycardia & fluid retention may be severe (combine with loop diuretic & b-blocker) ``` Causes hypertrichosis (also used topically to treat male pattern baldness) ```
38
pulmonary HTN
An increase in blood pressure in the pulmonary artery, pulmonary vein or pulmonary capillaries ``` Treatments • Prostaglandins (epoprostenol) • Inhibitors of endothelin synthesis and action (bosentan) • Vasodilators (sildenafil) ```
39
Epoprostenol
synthetic PGI Lowers peripheral, pulmonary, and coronary resistance Adverse effects include flushing, headache, jaw pain, diarrhea and arthralgias
40
Bosentan
Nonselective endothelin receptor blocker Blocks both the initial transient depressor (ETA) and the prolonged pressor (ETB) responses to endothelin Pregnancy category X
41
Sildenafil (vasodilator)
Inhibitor of phosphodiesterase 5 (PDE5) Increased cGMP → smooth muscle relaxation Adverse Effects: headache, flushing, dyspepsia, cyanopsia Contraindications: Nitrates
42
Angina Pectoris
paroxysmal and usually recurrent attacks of substernal or precordial chest discomfort caused by transient (15 seconds to 15 minutes) myocardial ischemia that is insufficient to induce myocyte necrosis eitopatho: consequence of the ischemia induced release of adenosine, bradykinin, and other molecules that stimulate sympathetic and vagal afferent nerves
43
stable or typical angina
most common form - has transient recurrent attacks associated with increased demand (PA) Due to reduction of coronary perfusion because of fixed stenosis Crushing or squeezing substernal pain, may radiate down the left arm Relieved by rest and vasodilators
44
prinzmetal or variant angina
Occurs at rest, awakens the patient from sleep Associated with ST segment elevation on ECG, of transmural ischemia occurs due to coronary artery spasm producing transient squeezing chest pain Responds to vasodilators
45
unstable (crescendo) angina
Pain that occurs with progressively increasing frequency and is precipitated with progressively less effort, often occurs at rest, and tends to be of more prolonged duration Induced by disruption of plaque with superimposed thrombosis and possibly vasospasm responds to vasodilators
46
transmural infarctions
Involve the full thickness of ventricular wall in the distribution of a single coronary artery (STEMI) Usually associated with acute plaque changes and superimposed, completely occlusive thrombosis Can also occur with Cocaine abuse
47
Subendocardial infarctions
Limited to the inner one third or at most one half of the ventricular wall also called NSTEMI Associated with diffuse stenosing coronary atherosclerosis or with prolonged hypotension (Global/Circumferential infarctions) May occur due to transient/partial arterial obstruction (Regional) Less serious than transmural infarction
48
histology of MI | gross?
``` 0-12 hours = wavy fibers and early coagulative necrosis not much (gross) change ``` 12-24 = early neutrophil filtrate dark mottling 1-3 days = heavy neutrophil filtrate mottling (yellow/tan center) 3-7 days = macrophages appear center softening / hyperemic border 7-10 = granulation tissue max softening 10-14 days = collagen deposition grayish discoloration 2 months+ = dense scar scarring complete
49
clinical features of MI
``` 1. chest pain retrosternal, crushing in nature may radiate the pain is persistent for >30 min (unlike angina) Not relieved by vasodilators or rest ``` 2. dyspnea 3. rapid weak pulse 4. diaphoresis, nausea and vomiting 5. silent MI (common in elderly)
50
Troponins (I and T) after MI
Most sensitive and specific marker Normally not detectable in circulation Rises in 3-12 hrs peaks at 24 - 48 hrs. and persists for 7-10 days
51
Creatine Kinase isoenzymes (CK-MB) after MI
A dimer composed of M & B subunits: MM, MB, BB CK-MB: most specific for the heart among the CKs Rises in 3-12 hrs Peaks at 18 - 24 hrs. and disappears by 48 - 72 hrs. Useful for detection of reinfarction
52
complications of MI
1. ischemic (Extension of the infarction, Reinfarction, Angina) 2. Arrhythmic: most common cause of SCD (Myocardial irritability and conduction disturbances, Electrolyte imbalance, Hypoxia) 3. Embolic: mural thrombi (common in LV).. can lead to systemic emboli stroke ``` 4. mechanical contractile dysfunction papillary muscle dysfunction myocardial rupture ventricular aneurysm ``` 5. inflammatory pericarditis Dresslers’ syndrome (autoimmune)
53
chronic ischemic heart disease
insidious onset of CHF in patients who have past episodes of MI or anginal attacks patho: cardiac decompensation owing to exhaustion of the compensatory hypertrophy of non- infarcted viable myocardium or severe coronary obstructive disease → diffuse myocardial dysfunction Arrhythmia, intercurrent MI are common and fatal gross: o Enlarged and heavy heart due to hypertrophy and dilation o Discrete gray white scars of healed previous infarcts o Patchy fibrous thickening of mural endocardium histo: o Myocardial hypertrophy o Diffuse subendocardial vacuolization - Myocytolysis o Scars of previously healed infarcts